The dose of Cnm-positive S. mutans used in this study was determined based on our previous mouse models of cerebral haemorrhage [13], ulcerative colitis [11], and non-alcoholic steatohepatitis [23], as well as a rat model of infective endocarditis [22]. Here, MTM1 is linked to metabolic dysfunction-associated steatohepatitis.